The National Cancer Institute (NCI) in Rockville, MD is currently accepting applications for their Rapid Access to Intervention Development (RAID) initiative. RAID aims to facilitate the translation of novel molecules and concepts from the laboratory to clinical trials by providing preclinical development resources to academic investigators on a competitive basis.
Through RAID, NCI's Developmental Therapeutics Program offers support in various preclinical development steps, such as production, manufacturing, formulation, and toxicology, to overcome obstacles in clinical translation. Suitable agents for RAID include small molecules, biologics, and vaccines, and requests for RAID support can be submitted twice a year, with the current deadline being February 1, 2003.
Generated from the website